Now showing items 1-10 of 10

    • A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions 

      Kjaer, Susanne K.; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Wheeler, Cosette M.; Perez, Gonzalo; Brown, Darron R.; Koutsky, Laura A.; Tay, Eng Hseon; García, Patricia; Ault, Kevin A.; Garland, Suzanne M.; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W.K.; Ferris, Daron G.; Paavonen, Jorma; Lehtinen, Matti; Steben, Marc; Bosch, F. Xavier; Dillner, Joakim; Joura, Elmar A.; Majewski, Slawomir; Muñoz, Nubia; Myers, Evan R.; Villa, Luisa L.; Taddeo, Frank J.; Roberts, Christine; Tadesse, Amha; Bryan, Janine; Maansson, Roger; Lu, Shuang; Vuocolo, Scott; Hesley, Teresa M.; Saah, Alfred; Barr, Eliav; Haupt, Richard M.
      "Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We provide an update on the efficacy of the quadrivalent ...
       Artículo. 2009
    • Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease 

      Joura, Elmar A; Ault, Kevin A; Bosch, F Xavier; Brown, Darron; Cuzick, Jack; Ferris, Daron; Garland, Suzanne M; Giuliano, Anna R; Hernandez-Avila, Mauricio; Huh, Warner; Iversen, Ole-Erik; Kjaer, Susanne K; Luna, Joaquin; Miller, Dianne; Monsonego, Joseph; Munoz, Nubia; Myers, Evan; Paavonen, Jorma; Pitisuttithum, Punnee; Steben, Marc; Wheeler, Cosette M; Perez, Gonzalo; Saah, Alfred; Luxembourg, Alain; Sings, Heather L; Velicer, Christine
      "Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV) types (6/11/ 16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the attribution of these HPV types in cervical ...
       Artículo. 2014
    • Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women 

      Clark, Liana R.; Myers, Evan R.; Huh, Warner; Joura, Elmar A.; Paavonen, Jorma; Perez, Gonzalo; James, Margaret K.; Sings, Heather L.; Haupt, Richard M.; Saah, Alfred J.; Garner, Elizabeth I.O.
      "Purpose: Human papillomavirus (HPV) is the causative agent of cervical cancer. Black women are disproportionally diagnosed and have higher mortality from cervical cancer in the United States. Here we describe the prophylactic ...
       Artículo. 2013
    • Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: Retrospective pooled analysis of trial data 

      Joura, Elmar A; Garland, Suzanne M; Paavonen, Jorma; Ferris, Daron G; Perez, Gonzalo; Ault, Kevin; Huh, Warner K; Sings, Heather L; James, Margaret K.; Haupt, Richard M
      Objectives To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on the risk of developing subsequent disease after an excisional procedure for cervical intraepithelial neoplasia or diagnosis of genital ...
       Artículo. 2012
    • HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine 

      Joura, Elmar A.; Kjaer, Susanne K.; Wheeler, Cosette M.; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Perez, Gonzalo; Brown, Darron R.; Koutsky, Laura A.; Tay, Eng Hseon; García, Patricia; Ault, Kevin A.; Garland, Suzanne M.; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W.K.; Ferris, Daron G.; Paavonen, Jorma; Lehtinen, Matti; Steben, Marc; Bosch, Xavier; Dillner, Joakim; Kurman, Robert J.; Majewski, Slawomir; Muñoz, Nubia; Myers, Evan R.; Villa, Luisa L.; Taddeo, Frank J.; Roberts, Christine; Tadesse, Amha; Bryan, Janine; Lupinacci, Lisa C.; Giacoletti, Katherine E.D.; Lu, Shuang; Vuocolo, Scott; Hesley, Teresa M.; Haupt, Richard M.; Barr, Eliav
      "The efficacy of the quadrivalent Human Papillomavirus (HPV) vaccine is thought to be mediated by humoral immunity. We evaluated the correlation between quadrivalent HPV vaccine-induced serum anti-HPV responses and efficacy. ...
       Artículo. 2008
    • Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region 

      Castellsagué, Xavier; Ault, Kevin A.; Bosch, F. Xavier; Brown, Darron; Cuzick, Jack; Ferris, Daron G.; Joura, Elmar A.; Garland, Suzanne M.; Giuliano, Anna R; Hernandez-Avila, Mauricio; Huh, Warner; Iversen, Ole-Erik; Kjaer, Susanne K.; Luna, Joaquin; Monsonego, Joseph; Muñoz, Nubia; Myers, Evan; Paavonen, Jorma; Pitisuttihum, Punnee; Steben, Marc; Wheeler, Cosette M.; Perez, Gonzalo; Saah, Alfred; Pitisuttihum, Punnee; Steben, Marc; Wheeler, Cosette M.; Perez, Gonzalo; Saah, Alfred; Luxembourg, Alain; Sings, Heather L; Velicer, Christine
      Background: We estimated the proportion of cervical intraepithelial neoplasia (CIN) cases attributed to 14 HPV types, including quadrivalent (qHPV) (6/11/16/18) and 9-valent (9vHPV) (6/11/16/18/31/33/45/52/58) vaccine ...
       Artículo. 2016
    • Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15–26 Years of Age 

      Garland, Suzanne M.; Joura, Elmar A.; Ault, Kevin A.; Bosch, F. Xavier; Brown, Darron R.; Castellsagué, Xavier; Ferenczy, Alex; Ferris, Daron G.; Giuliano, Anna R.; Hernandez-Avila, Mauricio; Huh, Warner K.; Iversen, Ole-Erik; Kjaer, Susanne K.; Kurman, Robert J.; Luna, Joaquin; Monsonego, Joseph; Muñoz, Nubia; Paavonen, Jorma; Pitisuttihum, Punnee; Ronnett, Brigitte M.; Steben, Marc; Stoler, Mark H.; Wheeler, Cosette M.; Wiley, Dorothy J.; Perez, Gonzalo; Saah, Alfred J.; Luxembourg, Alain; Li; DiNubile, Mark J.; Wagner, Monika; Velicer, Christine
      OBJECTIVE: To estimate the proportion of vulvar and vaginal low-grade and high-grade squamous intraepithelial lesions (LSILs and HSILs) in females 15-26 years of age attributable to 14 human papillomavirus (HPV) genotypes ...
       Artículo. 2018
    • Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women 

      Muñoz, Nubia; Kjaer, Susanne K.; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Wheeler, Cosette M.; Perez, Gonzalo; Brown, Darron R.; Koutsky, Laura A.; Tay, Eng Hseon; Garcia, Patricía J.; Ault, Kevin A.; Garland, Suzanne M.; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W. K.; Ferris, Daron G.; Paavonen, Jorma; Steben, Marc; Bosch, F. Xavier; Dillner, Joakim; Huh, Warner K.; Joura, Elmar A.; Kurman, Robert J.; Majewski, Slawomir; Myers, Evan R.; Villa, Luisa L.; Taddeo, Frank J.; Roberts, Christine; Tadesse, Amha; Bryan, Janine T.; Lupinacci, Lisa C.; Giacoletti, Katherine E. D.; Sings, Heather L.; James, Margaret K.; Hesley, Teresa M.; Barr, Eliav; Haupt, Richard M.
      "Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually ...
       Artículo. 2010
    • "Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women" 

      Insinga, Ralph P.; Perez, Gonzalo; Wheeler, Cosette M.; Koutsky, Laura A.; Garland, Suzanne M.; Leodolter, Sepp; Joura, Elmar A.; Ferris, Daron G.; Steben, Marc; Brown, Darron R.; Elbasha, Elamin H.; Paavonen, Jorma; Haupt, Richard M.
      "Background: We describe the incidence and duration of cervical human papillomavirus (HPV) infection episodes along with the risk of infection reappearance following a period of nondetection. Methods:Women (1,788) ages 16 ...
       Artículo. 2010
    • "The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years" 

      Brown, Darron R; Kjaer, Susanne K; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Wheeler, Cosette M; Perez, Gonzalo; Koutsky, Laura A; Tay, Eng Hseon; Garcia, Patricía; Ault, Kevin A; Garland, Suzanne M; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W K; Ferris, Daron G; Paavonen, Jorma; Steben, Marc; Bosch, F Xavier; Dillner, Joakim; Joura, Elmar A; Kurman, Robert J; Majewski, Slawomir; Muñoz, Nubia; Myers, Evan R; Villa, Luisa L; Taddeo, Frank J; Roberts, Christine; Tadesse, Amha; Bryan, Janine; Lupinacci, Lisa C; Giacoletti, Katherine E D; Sings, Heather L; James, Margaret; Hesley, Teresa M; Barr, Eliav
      "Background. Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated ...
       Artículo. 2009